Clinical Trial Update: XLIF® vs. MAS®TLIF for the Treatment of Symptomatic Lumbar Degenerative Spondylolisthesis With or Without Central Stenosis.

View source ↗

Summary

A completed clinical trial comparing XLIF and MAS TLIF for symptomatic lumbar degenerative spondylolisthesis with or without central stenosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Degenerative Spondylolisthesis

Snippet

Sponsor: NuVasive | Conditions: Spondylolisthesis | Status: COMPLETED